Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: Implication for photodynamic therapy of prostate cancer

Pradip Chakrabarti, Eduardo Orihuela, Norman Egger, Durwood Earnest Neal, Rama Gangula, Adekunle Adesokun, Massoud Motamedi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND. Delta-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) is currently being investigated for the treatment of prostate diseases. In this study, we evaluate 1) the in vitro production of protoporphyrin IX (PPIX) (the active photosensitizing agent of ALA-mediated PDT) by two different prostate cancer cell lines (LNCaP and Pc-3) and a benign, modified, prostatic cell line (TP-2), and 2) the extent of PDT- induced cell injury, as determined by electron microscopy (EM) and cell survival. METHODS. The cell lines were assigned into four treatment groups: group 1, control, no ALA and no light irradiation; group 2, dark control, ALA only; group 3, light control, radiation only; and group 4, PDT, ALA followed by irradiation (630 nm, 3 joules/cm2). The experiments were performed in triplicate. ALA concentration was 50 μg/ml of media in all instances. RESULTS. Following incubation with ALA, PPIX production was significantly increased in the three cell lines studied, and more notably in the PC-3 cell line. Compared to controls, EM and cell survival studies demonstrated significant mitochondrial damage and decreased survival, respectively, in the cells treated with PDT. This was also more evident in the PC-3 cell line. CONCLUSIONS. Our results demonstrate that prostate cells differ in their response to ALA-mediated PDT. This response appears to depend on the intracellular production of PPIX and the cell type, i.e., on the functional and structural characteristics of the cell mitochondria. In addition, our results suggest that PDT might be effective at killing prostate cancer cells.

Original languageEnglish (US)
Pages (from-to)211-218
Number of pages8
JournalProstate
Volume36
Issue number4
DOIs
StatePublished - Sep 1 1998
Externally publishedYes

Fingerprint

Photosensitivity Disorders
Aminolevulinic Acid
Photochemotherapy
Prostate
Prostatic Neoplasms
Cell Line
Cell Survival
Electron Microscopy
Light
Photosensitizing Agents
Mitochondria
Radiation
Control Groups
Wounds and Injuries

Keywords

  • Delta-aminolevulinic acid
  • LNCaP
  • PC- 3
  • Photodynamic therapy
  • Prostate cancer
  • TP-2 cell lines

ASJC Scopus subject areas

  • Urology

Cite this

Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines : Implication for photodynamic therapy of prostate cancer. / Chakrabarti, Pradip; Orihuela, Eduardo; Egger, Norman; Neal, Durwood Earnest; Gangula, Rama; Adesokun, Adekunle; Motamedi, Massoud.

In: Prostate, Vol. 36, No. 4, 01.09.1998, p. 211-218.

Research output: Contribution to journalArticle

Chakrabarti, Pradip ; Orihuela, Eduardo ; Egger, Norman ; Neal, Durwood Earnest ; Gangula, Rama ; Adesokun, Adekunle ; Motamedi, Massoud. / Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines : Implication for photodynamic therapy of prostate cancer. In: Prostate. 1998 ; Vol. 36, No. 4. pp. 211-218.
@article{d47d6bfa47ee4f2ab62fe857eb1c5eef,
title = "Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: Implication for photodynamic therapy of prostate cancer",
abstract = "BACKGROUND. Delta-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) is currently being investigated for the treatment of prostate diseases. In this study, we evaluate 1) the in vitro production of protoporphyrin IX (PPIX) (the active photosensitizing agent of ALA-mediated PDT) by two different prostate cancer cell lines (LNCaP and Pc-3) and a benign, modified, prostatic cell line (TP-2), and 2) the extent of PDT- induced cell injury, as determined by electron microscopy (EM) and cell survival. METHODS. The cell lines were assigned into four treatment groups: group 1, control, no ALA and no light irradiation; group 2, dark control, ALA only; group 3, light control, radiation only; and group 4, PDT, ALA followed by irradiation (630 nm, 3 joules/cm2). The experiments were performed in triplicate. ALA concentration was 50 μg/ml of media in all instances. RESULTS. Following incubation with ALA, PPIX production was significantly increased in the three cell lines studied, and more notably in the PC-3 cell line. Compared to controls, EM and cell survival studies demonstrated significant mitochondrial damage and decreased survival, respectively, in the cells treated with PDT. This was also more evident in the PC-3 cell line. CONCLUSIONS. Our results demonstrate that prostate cells differ in their response to ALA-mediated PDT. This response appears to depend on the intracellular production of PPIX and the cell type, i.e., on the functional and structural characteristics of the cell mitochondria. In addition, our results suggest that PDT might be effective at killing prostate cancer cells.",
keywords = "Delta-aminolevulinic acid, LNCaP, PC- 3, Photodynamic therapy, Prostate cancer, TP-2 cell lines",
author = "Pradip Chakrabarti and Eduardo Orihuela and Norman Egger and Neal, {Durwood Earnest} and Rama Gangula and Adekunle Adesokun and Massoud Motamedi",
year = "1998",
month = "9",
day = "1",
doi = "10.1002/(SICI)1097-0045(19980901)36:4<211::AID-PROS1>3.0.CO;2-I",
language = "English (US)",
volume = "36",
pages = "211--218",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines

T2 - Implication for photodynamic therapy of prostate cancer

AU - Chakrabarti, Pradip

AU - Orihuela, Eduardo

AU - Egger, Norman

AU - Neal, Durwood Earnest

AU - Gangula, Rama

AU - Adesokun, Adekunle

AU - Motamedi, Massoud

PY - 1998/9/1

Y1 - 1998/9/1

N2 - BACKGROUND. Delta-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) is currently being investigated for the treatment of prostate diseases. In this study, we evaluate 1) the in vitro production of protoporphyrin IX (PPIX) (the active photosensitizing agent of ALA-mediated PDT) by two different prostate cancer cell lines (LNCaP and Pc-3) and a benign, modified, prostatic cell line (TP-2), and 2) the extent of PDT- induced cell injury, as determined by electron microscopy (EM) and cell survival. METHODS. The cell lines were assigned into four treatment groups: group 1, control, no ALA and no light irradiation; group 2, dark control, ALA only; group 3, light control, radiation only; and group 4, PDT, ALA followed by irradiation (630 nm, 3 joules/cm2). The experiments were performed in triplicate. ALA concentration was 50 μg/ml of media in all instances. RESULTS. Following incubation with ALA, PPIX production was significantly increased in the three cell lines studied, and more notably in the PC-3 cell line. Compared to controls, EM and cell survival studies demonstrated significant mitochondrial damage and decreased survival, respectively, in the cells treated with PDT. This was also more evident in the PC-3 cell line. CONCLUSIONS. Our results demonstrate that prostate cells differ in their response to ALA-mediated PDT. This response appears to depend on the intracellular production of PPIX and the cell type, i.e., on the functional and structural characteristics of the cell mitochondria. In addition, our results suggest that PDT might be effective at killing prostate cancer cells.

AB - BACKGROUND. Delta-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) is currently being investigated for the treatment of prostate diseases. In this study, we evaluate 1) the in vitro production of protoporphyrin IX (PPIX) (the active photosensitizing agent of ALA-mediated PDT) by two different prostate cancer cell lines (LNCaP and Pc-3) and a benign, modified, prostatic cell line (TP-2), and 2) the extent of PDT- induced cell injury, as determined by electron microscopy (EM) and cell survival. METHODS. The cell lines were assigned into four treatment groups: group 1, control, no ALA and no light irradiation; group 2, dark control, ALA only; group 3, light control, radiation only; and group 4, PDT, ALA followed by irradiation (630 nm, 3 joules/cm2). The experiments were performed in triplicate. ALA concentration was 50 μg/ml of media in all instances. RESULTS. Following incubation with ALA, PPIX production was significantly increased in the three cell lines studied, and more notably in the PC-3 cell line. Compared to controls, EM and cell survival studies demonstrated significant mitochondrial damage and decreased survival, respectively, in the cells treated with PDT. This was also more evident in the PC-3 cell line. CONCLUSIONS. Our results demonstrate that prostate cells differ in their response to ALA-mediated PDT. This response appears to depend on the intracellular production of PPIX and the cell type, i.e., on the functional and structural characteristics of the cell mitochondria. In addition, our results suggest that PDT might be effective at killing prostate cancer cells.

KW - Delta-aminolevulinic acid

KW - LNCaP

KW - PC- 3

KW - Photodynamic therapy

KW - Prostate cancer

KW - TP-2 cell lines

UR - http://www.scopus.com/inward/record.url?scp=0031866182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031866182&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0045(19980901)36:4<211::AID-PROS1>3.0.CO;2-I

DO - 10.1002/(SICI)1097-0045(19980901)36:4<211::AID-PROS1>3.0.CO;2-I

M3 - Article

C2 - 9719020

AN - SCOPUS:0031866182

VL - 36

SP - 211

EP - 218

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 4

ER -